| Trial ID: | L0933 |
| Source ID: | NCT04818151
|
| Associated Drug: |
Warfarin
|
| Title: |
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Venous Thromboembolic Disease|Kidney Failure, Chronic
|
| Interventions: |
DRUG: Warfarin|DRUG: Apixaban
|
| Outcome Measures: |
Primary: Bleeding occurrence, Number of bleeding occurrences., 3 months|Recurrent thrombosis occurrence, Number of recurrent thrombosis occurrences., 3 months | Secondary: Days in acute care, Number of hospital days/ED utilization., 3 months
|
| Sponsor/Collaborators: |
Sponsor: Johns Hopkins University | Collaborators: Bristol-Myers Squibb
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
14914
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2021-01-01
|
| Completion Date: |
2021-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2021-07-26
|
| Locations: |
Johns Hopkins University, Baltimore, Maryland, 21287, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT04818151
|
